Unknown

Dataset Information

0

Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson's Disease Patients.


ABSTRACT: In Parkinson's disease (PD) research, human neuroblastoma and immortalized neural cell lines have been widely used as in vitro models. The advancement in the field of reprogramming technology has provided tools for generating patient-specific induced pluripotent stem cells (hiPSCs) as well as human induced neuronal progenitor cells (hiNPCs). These cells have revolutionized the field of disease modeling, especially in neural diseases. Although the direct reprogramming to hiNPCs has several advantages over differentiation after hiPSC reprogramming, such as the time required and the simple procedure, relatively few studies have utilized hiNPCs. Here, we optimized the protocol for hiNPC reprogramming using pluripotency factors and Sendai virus. In addition, we generated hiNPCs of two healthy donors, a sporadic PD patient, and a familial patient with the LRRK2 G2019S mutation (L2GS). The four hiNPC cell lines are highly proliferative, expressed NPC markers, maintained the normal karyotype, and have the differentiation potential of dopaminergic neurons. Importantly, the patient hiNPCs show different apoptotic marker expression. Thus, these hiNPCs, in addition to hiPSCs, are a favorable option to study PD pathology.

SUBMITTER: Lee M 

PROVIDER: S-EPMC6881039 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson's Disease Patients.

Lee Minhyung M   Sim Hyuna H   Ahn Hyunjun H   Ha Jeongmin J   Baek Aruem A   Jeon Young-Joo YJ   Son Mi-Young MY   Kim Janghwan J  

International journal of stem cells 20191101 3


In Parkinson's disease (PD) research, human neuroblastoma and immortalized neural cell lines have been widely used as <i>in vitro</i> models. The advancement in the field of reprogramming technology has provided tools for generating patient-specific induced pluripotent stem cells (hiPSCs) as well as human induced neuronal progenitor cells (hiNPCs). These cells have revolutionized the field of disease modeling, especially in neural diseases. Although the direct reprogramming to hiNPCs has several  ...[more]

Similar Datasets

| S-EPMC3931081 | biostudies-literature
| S-EPMC3093517 | biostudies-other
| S-EPMC5995754 | biostudies-literature
2023-08-31 | GSE157394 | GEO
| S-EPMC6083049 | biostudies-literature
2023-08-31 | GSE157392 | GEO
| S-EPMC7526135 | biostudies-literature
2023-08-31 | GSE157340 | GEO
| S-EPMC10932627 | biostudies-literature
2013-10-24 | E-GEOD-51580 | biostudies-arrayexpress